NCT00109746View on ClinicalTrials.gov

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2010

Conditions
Insulin ResistanceHIV Infections
Interventions
DIETARY_SUPPLEMENT

chromium picolinate

HIV+ and control may receive 500µg of chromium picolinate or placebo twice daily for two months.

Trial Locations (1)

11794

State University of New York/General Clinical Research Center, Stony Brook

All Listed Sponsors
collaborator

Office of Dietary Supplements (ODS)

NIH

lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00109746 - Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults | Biotech Hunter | Biotech Hunter